Novartis

Novartis Debt / Assets

The Debt-to-Assets Ratio of Novartis (NOVN.SW) as of Nov 21, 2026 is 0.38. In the previous year, Debt-to-Assets Ratio was 0.38 — a change of 0.19% (higher).

Debt / Assets

0.38

YoY

0.19%

Last updated:

Debt-to-Assets Ratio of Novartis is 2025 0.38 . Debt-to-Assets Ratio of Novartis was 2024 0.38 . It decreases by 0.19% higher compared to the previous year.

The Novartis Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
0.27 USD
Jan 1, 2019
0.30 USD
Jan 1, 2020
0.36 USD
Jan 1, 2021
0.29 USD
Jan 1, 2022
0.29 USD
Jan 1, 2023
0.32 USD
Jan 1, 2024
0.38 USD
Jan 1, 2025
0.38 USD
The Novartis Debt / Assets history
YEARDebt / AssetsYoY
0.38+0.19%
0.38+15.97%
0.32+10.94%
0.29+0.94%
0.29-20.54%
0.36+20.31%
0.30+11.70%
0.27+3.21%
0.26+17.34%
0.22+9.34%
0.20+2.53%
0.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novartis Stock analysis

What does Novartis do? Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novartis stock

Debt-to-Assets Ratio of Novartis is 0.38 in 2025.

Debt-to-Assets Ratio of Novartis changed from 0.38 to 0.38, representing a 0.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Novartis since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Novartis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Novartis

All Key Metrics — Novartis